We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
Cap. Flow
+$73.4M
Cap. Flow %
1.52%
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$48.8M
2
CMCSA icon
Comcast
CMCSA
+$46.9M
3
AVY icon
Avery Dennison
AVY
+$38.5M
4
MIDD icon
Middleby
MIDD
+$33M
5
LKQ icon
LKQ Corp
LKQ
+$32.3M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$63.1M
2
TROW icon
T. Rowe Price
TROW
+$47.7M
3
ISRG icon
Intuitive Surgical
ISRG
+$39M
4
PAA icon
Plains All American Pipeline
PAA
+$39M
5
SHW icon
Sherwin-Williams
SHW
+$38.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.65%
2 Financials 14.81%
3 Industrials 14.31%
4 Technology 11.57%
5 Energy 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
226
Eli Lilly
LLY
$1.05T
$1.02M 0.02%
20,327
-253
-1% -$13.2K
ALGN icon
227
Align Technology
ALGN
$11.3B
$1.02M 0.02%
21,210
+7,895
+59% +$345K
FIVE icon
228
Five Below
FIVE
$13.7B
$1.02M 0.02%
+23,230
New +$932K
BLK icon
229
Blackrock
BLK
$181B
$1M 0.02%
3,703
+25
+0.7% +$6.79K
SPLK
230
DELISTED
Splunk Inc
SPLK
$977K 0.02%
16,265
+4,220
+35% +$225K
SIRO
231
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$966K 0.02%
14,437
-13,349
-48% -$901K
ABBV icon
232
AbbVie
ABBV
$456B
$952K 0.02%
21,276
-2,088
-9% -$92.6K
CVS icon
233
CVS Health
CVS
$119B
$945K 0.02%
16,651
-1,562
-9% -$93.1K
IVV icon
234
iShares Core S&P 500 ETF
IVV
$900B
$945K 0.02%
5,593
+29
+0.5% +$4.89K
WFT
235
DELISTED
Weatherford International plc
WFT
$940K 0.02%
+61,350
New +$900K
EW icon
236
Edwards Lifesciences
EW
$51.8B
$936K 0.02%
80,616
-7,650
-9% -$89.5K
MDY icon
237
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$935K 0.02%
4,133
-80
-2% -$17.8K
PBR icon
238
Petrobras
PBR
$118B
$929K 0.02%
+59,942
New +$854K
TMO icon
239
Thermo Fisher Scientific
TMO
$233B
$929K 0.02%
10,085
+2,285
+29% +$207K
ITW icon
240
Illinois Tool Works
ITW
$80.2B
$913K 0.02%
11,973
+689
+6% +$50.4K
TLGT
241
DELISTED
Teligent, Inc
TLGT
$912K 0.02%
50,093
-1,657
-3% -$27.9K
VIXY icon
242
ProShares VIX Short-Term Futures ETF
VIXY
$212M
$904K 0.02%
14
-2
-13% -$135K
MMM icon
243
3M
MMM
$92.2B
$900K 0.02%
9,013
-1,512
-14% -$147K
ALXN
244
DELISTED
Alexion Pharmaceuticals
ALXN
$894K 0.02%
7,695
-45
-0.6% -$4.94K
AHT.PRD
245
Ashford Hospitality Trust Series D
AHT.PRD
$7.77M
$881K 0.02%
+34,890
New +$882K
FCX icon
246
Freeport-McMoran
FCX
$113B
$875K 0.02%
26,445
+1,229
+5% +$37.6K
LOW icon
247
Lowe's Companies
LOW
$116B
$854K 0.02%
17,933
+11,300
+170% +$513K
ENV
248
DELISTED
ENVESTNET, INC.
ENV
$839K 0.02%
27,065
+8,655
+47% +$240K
VOD icon
249
Vodafone
VOD
$36.7B
$835K 0.02%
23,293
-668
-3% -$21.1K
ERF
250
DELISTED
Enerplus Corporation
ERF
$830K 0.02%
50,399
-2,045
-4% -$33.5K
8 9
10
11 12

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
  • Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
  • Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
  • Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
  • Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
  • Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.

Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.